BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30
• 31

• Drug Development

  Cyclacel Pharmaceuticals, Inc.’s CYC065 Demonstrates Promising Activity In Uterine Serous Carcinoma In Preclinical Data Published By Independent Academic Researchers

  August 2, 2016

   · 

  7 min read
• Business

  Catalyst Biosciences Announces Agreement to Sell Three NNR Assets To Attenua

  August 2, 2016

   · 

  3 min read
• ReWalk Announces Launch Of 522 Post-Market Study With Stanford University School of Medicine As Lead Investigator Site

  August 2, 2016

   · 

  4 min read
• Pharm Country

  Edge Therapeutics Announces Closing Of $20 Million Debt Facility With Hercules Capital

  August 2, 2016

   · 

  3 min read
• Business

  Vitae Pharma To Announce Second Quarter 2016 Financial Results On August 3, 2016

  August 2, 2016

   · 

  1 min read
• Drug Development

  VM BioPharma Announces Korea Food And Drug Administration Approval Of Phase 2 Clinical Trial For Investigational Gene Therapy VM202 In Ischemic Heart Disease

  August 2, 2016

   · 

  6 min read
• Business

  Aquinox To Announce Second Quarter 2016 Financial Results

  August 2, 2016

   · 

  1 min read
• MEDA Shareholders Representing Approximately 94% Of Meda Shares Accept Mylan Offer

  August 2, 2016

   · 

  12 min read
• Genetown

  NeuroMetrix Reports That The Quell Health Cloud Has Collected Over 1 Million Hours Of Quell Therapy And Health Data

  August 2, 2016

   · 

  3 min read
• Policy

  Agilis Biotherapeutics Announces FDA Orphan Drug Designation For The Treatment Of Friedreich’s Ataxia (FA)

  August 2, 2016

   · 

  4 min read